State & FederalMedicaidJanuary 31, 2021

Colorectal Cancer Screening (COL) - ensuring quality of care

Beginning January 1, 2024, Empire became Anthem. This article, published under the former brand, now applies to Anthem.

This HEDIS® measure evaluates the percentage of members’ age 50 to 75 who had appropriate screening for colorectal cancer.

 

Record your efforts

Document (date and result) one or more of these screenings:

  • Colonoscopy during measurement year or nine years prior
  • Fecal occult blood test (FOBT) during measurement year
  • CT colonography during measurement year or four years prior
  • Fecal immunochemical test (FIT)-DNA test during measurement year or two years prior
  • Flexible sigmoidoscopy during measurement year or four years prior

 

Exclusions:

  • Diagnosis of colorectal cancer
  • Total colectomy
  • Members who receive palliative care

 

Need help getting your patients screened for colorectal cancer?

As an option, participating providers can order FIT kits through Quest Diagnostics.®* Quest will ship InSure® ONE™ FIT kits directly to your practice. To order:

  • Online, use the Quest Quanum® Lab Services Manager. Create an account at https://bit.ly/3qLxNPh.
  • Via phone, call 1-866-MY-QUEST and state supplies for assistance.

 

Quest will ship the kits to your practice at no cost, based on usage and test completion.

 

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

 

* Quest Diagnostics is an independent company providing ectal cancer screening materials on behalf of Empire BlueCross BlueShield HealthPlus.

 

NYEPEC-2597-20 December 2020

 

PUBLICATIONS: February 2021 Empire Provider News